Results 11 to 20 of about 48,580 (292)

t(12;17)(p13;p13) [PDF]

open access: yesAtlas of Genetics and Cytogenetics in Oncology and Haematology, 2011
Review on t(12;17)(p13;p13), with data on clinics, and the genes involved.
Huret, JL, JL Huret
openaire   +4 more sources

dic(9;12)(p13;p13) PAX5/ETV6 [PDF]

open access: yesAtlas of Genetics and Cytogenetics in Oncology and Haematology, 2018
Review on dic(9;12)(p13;p13) PAX5/ETV6, with data on clinics and the genes involved.
Huret, Jean-Loup
openaire   +4 more sources

t(7;12)(q34;p13) - t(12;14)(p13;q11) [PDF]

open access: yesAtlas of Genetics and Cytogenetics in Oncology and Haematology, 2011
Review on t(7;12)(q34;p13) - t(12;14)(p13;q11), with data on clinics, and the genes involved.
E Clappier, J Soulier
openaire   +3 more sources

t(2;12)(p12;p13) - t(12;14)(p13;q32) - t(12;22)(p13;q11) [PDF]

open access: yesAtlas of Genetics and Cytogenetics in Oncology and Haematology, 2011
Review on t(2;12)(p12;p13) - t(12;14)(p13;q32) - t(12;22)(p13;q11), with data on clinics, and the genes involved.
Huret, JL, JL Huret
openaire   +4 more sources

dic(9;12)(p13;p13) [PDF]

open access: yesAtlas of Genetics and Cytogenetics in Oncology and Haematology, 2011
Review on dic(9;12)(p13;p13), with data on clinics, and the genes ...
Huret, JL
core   +7 more sources

t(11;14)(p13;q11) - t(7;11)(q35;p13) [PDF]

open access: yesAtlas of Genetics and Cytogenetics in Oncology and Haematology, 2011
Review on t(11;14)(p13;q11) - t(7;11)(q35;p13), with data on clinics, and the genes involved.
Bilhou-Nabera, C
openaire   +3 more sources

t(12;19)(p13;p13) [PDF]

open access: yesAtlas of Genetics and Cytogenetics in Oncology and Haematology, 2011
Review on t(12;19)(p13;p13), with data on clinics, and the genes ...
P Gorello, Starza R La, C Mecucci
openaire   +3 more sources

Comparative effectiveness of the biosimilar CT-P13

open access: yesJournal of Comparative Effectiveness Research, 2017
The first biosimilar infliximab, CT-P13 (infliximab-dyyb) has been used for the treatment of inflammatory diseases for 4 years. CT-P13 has highly similar efficacy and safety profiles with a lower price than the originator infliximab and has been approved in 81 countries.
Dae Hyun Yoo
core   +4 more sources

p13 from group II baculoviruses is a killing-associated gene [PDF]

open access: yesBMB Reports, 2012
p13 gene was first described in Leucania separata multinuclearpolyhedrosis virus (Ls-p13) several years ago, but the functionof P13 protein has not been experimentally investigated todate.
Yipeng Qi
doaj   +1 more source

CT-P13: design, development, and place in therapy

open access: yesDrug Design, Development and Therapy, 2017
Tommaso Gabbani,1 Simona Deiana,2 Vito Annese3 1Gastroenterology Unit, Morgagni-Pierantoni Hospital, AUSL Romagna, Forlì, 2Division of Gastroenterology, AOU Careggi University Hospital, Florence, Italy; 3Gastroenterology Department, Valiant ...
Gabbani T, Deiana S, Annese V
doaj   +2 more sources

Home - About - Disclaimer - Privacy